Marie Emms, Global Patient Recruitment Director at inVentiv Health says that “we need to ensure that sites know how to communicate effectively with their patients and that they have an action plan and goals in place for how and when they will enroll patients to the study.” This article talks about the various challenges that sponsors, CROs and sites face in recruiting and retaining rare disease patients in clinical trials.
This content is repurposed from PharmaVOICE.
